Condition | Indicated | Relationship Strength | Studies | Trials |
Fatty Liver, Nonalcoholic [description not available] | 0 | 7.36 | 5 | 3 |
HIV Coinfection [description not available] | 0 | 16.05 | 47 | 24 |
HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). | 0 | 16.05 | 47 | 24 |
Non-alcoholic Fatty Liver Disease Fatty liver finding without excessive ALCOHOL CONSUMPTION. | 0 | 7.36 | 5 | 3 |
Hepatocellular Carcinoma [description not available] | 0 | 3.64 | 1 | 1 |
Cancer of Liver [description not available] | 0 | 3.64 | 1 | 1 |
Hepatitis INFLAMMATION of the LIVER. | 0 | 3.64 | 1 | 1 |
Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. | 0 | 3.64 | 1 | 1 |
Liver Neoplasms Tumors or cancer of the LIVER. | 0 | 3.64 | 1 | 1 |
HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. | 0 | 5.74 | 2 | 1 |
Lipodystrophy A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy. | 0 | 13.4 | 11 | 2 |
Diabetes Mellitus, Adult-Onset [description not available] | 0 | 5.69 | 2 | 1 |
Insulin Sensitivity [description not available] | 0 | 5.7 | 2 | 1 |
Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. | 0 | 5.69 | 2 | 1 |
Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. | 0 | 5.7 | 2 | 1 |
Dyslipidemia [description not available] | 0 | 4.48 | 3 | 0 |
Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. | 0 | 6.67 | 4 | 1 |
Dyslipidemias Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL. | 0 | 4.48 | 3 | 0 |
Liver Steatosis [description not available] | 0 | 6.77 | 5 | 1 |
Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. | 0 | 6.77 | 5 | 1 |
Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). | 0 | 7.62 | 6 | 2 |
Innate Inflammatory Response [description not available] | 0 | 5.83 | 2 | 2 |
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 5.83 | 2 | 2 |
Cognitive Decline [description not available] | 0 | 4.39 | 1 | 1 |
Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. | 0 | 5.71 | 2 | 1 |
Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. | 0 | 4.39 | 1 | 1 |
Atherogenesis [description not available] | 0 | 3 | 1 | 0 |
Atherosclerosis A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. | 0 | 3 | 1 | 0 |
Sarcopenia Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles. | 0 | 3 | 1 | 0 |
Adenohypophyseal Hyposecretion [description not available] | 0 | 4.4 | 1 | 1 |
Hypopituitarism Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions. | 0 | 4.4 | 1 | 1 |
HIV Lipodystrophy Syndrome [description not available] | 0 | 14.89 | 32 | 16 |
HIV-Associated Lipodystrophy Syndrome Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors. | 0 | 14.89 | 32 | 16 |
Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE. | 0 | 3.37 | 2 | 0 |
Abdominal Obesity [description not available] | 0 | 8.63 | 5 | 1 |
Cardiac Diseases [description not available] | 0 | 2.05 | 1 | 0 |
Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. | 0 | 2.05 | 1 | 0 |
Airflow Obstruction, Chronic [description not available] | 0 | 2.06 | 1 | 0 |
Weight Reduction [description not available] | 0 | 2.06 | 1 | 0 |
Cachexia General ill health, malnutrition, and weight loss, usually associated with chronic disease. | 0 | 2.06 | 1 | 0 |
Weight Loss Decrease in existing BODY WEIGHT. | 0 | 2.06 | 1 | 0 |
Pulmonary Disease, Chronic Obstructive A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA. | 0 | 2.06 | 1 | 0 |
Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. | 0 | 2.94 | 1 | 0 |
Intertrochanteric Fractures [description not available] | 0 | 2.94 | 1 | 0 |
Long Sleeper Syndrome [description not available] | 0 | 2.94 | 1 | 0 |
AIDS Wasting Syndrome [description not available] | 0 | 2.94 | 1 | 0 |
Hip Fractures Fractures of the FEMUR HEAD; the FEMUR NECK; (FEMORAL NECK FRACTURES); the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region (FEMORAL FRACTURES). | 0 | 2.94 | 1 | 0 |
Sleep Wake Disorders Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle. | 0 | 2.94 | 1 | 0 |
HIV Wasting Syndrome Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. (From Harrison's Principles of Internal Medicine, 13th ed, p1611). | 0 | 2.94 | 1 | 0 |
Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. | 0 | 2.03 | 1 | 0 |